|
|
News Breaks
|
November 23, 2009
|
| 12:38 EDT |  | CEPH |
| theflyonthewall.com: | Cephalon Reslizumab drug "is not dead," says Collins Stewart | | Collins Stewart believes that despite negative data results for Reslizumab, Cephalon's drug "is not dead." The firm finds the valuation on shares compelling, but remains on the sidelines with a Hold rating due to a lack of long-term visibility. :theflyonthewall.com |
|
|
News For CEPH From The Last 14 Days Check below for free stories on CEPH the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
